Net Profit Margins
Abbott Laboratories’s revenue jumped 29.68% since last year same period to $6335Mn in the Q1 2017. On a quarterly growth basis, Abbott Laboratories has generated 18.79% jump in its revenue since last 3-months.
Abbott Laboratories’s net profit jumped 32.59% since last year same period to $419Mn in the Q1 2017. On a quarterly growth basis, Abbott Laboratories has generated -47.49% fall in its net profits since last 3-months.
Abbott Laboratories’s net profit margin jumped 2.25% since last year same period to 6.61% in the Q1 2017. On a quarterly growth basis, Abbott Laboratories has generated -55.8% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter
EPS Estimate Current Year
Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 0.91 - a -3.19% fall from last quarter’s estimates.
Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 0.91.
Earning Per Share (EPS)
Return on Assets (ROA)
Return on Equity (ROE)
Dividend Per Share (DPS)
Abbott Laboratories’s earning per share (EPS) fell -17.86% since last year same period to 1.15 in the Q3 2022. This indicates that the Abbott Laboratories has generated -17.86% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Abbott Laboratories’s return on assets (ROA) stands at 0.09.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Abbott Laboratories’s return on equity (ROE) stands at 0.19.
Abbott Laboratories declared 0.47 dividend per share during the earnings announcement for Q3 2022.
|Earnings Date||Estimated EPS||Reported EPS||Surprise %|
100 Abbott Park Road, North Chicago, IL, United States, 60064-6400
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*